NO20000202L - Immunogene konjugater som omfatter en gruppe B- meningokokkporin og et H. influenzae-polysakkarid - Google Patents

Immunogene konjugater som omfatter en gruppe B- meningokokkporin og et H. influenzae-polysakkarid

Info

Publication number
NO20000202L
NO20000202L NO20000202A NO20000202A NO20000202L NO 20000202 L NO20000202 L NO 20000202L NO 20000202 A NO20000202 A NO 20000202A NO 20000202 A NO20000202 A NO 20000202A NO 20000202 L NO20000202 L NO 20000202L
Authority
NO
Norway
Prior art keywords
group
immunogenic conjugates
influenzae polysaccharide
meningococcal porin
porin
Prior art date
Application number
NO20000202A
Other languages
English (en)
Other versions
NO20000202D0 (no
Inventor
Milan S Blake
Francis Michon
Peter C Fusco
Iver Heron
Original Assignee
North American Vaccine Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by North American Vaccine Inc filed Critical North American Vaccine Inc
Publication of NO20000202D0 publication Critical patent/NO20000202D0/no
Publication of NO20000202L publication Critical patent/NO20000202L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/646—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6068—Other bacterial proteins, e.g. OMP

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20000202A 1997-07-17 2000-01-14 Immunogene konjugater som omfatter en gruppe B- meningokokkporin og et H. influenzae-polysakkarid NO20000202L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US5295297P 1997-07-17 1997-07-17
US5779597P 1997-09-08 1997-09-08
PCT/US1998/014838 WO1999003501A1 (en) 1997-07-17 1998-07-17 Immunogenic conjugates comprising a group b meningococcal porin and an h. influenzae polysaccharide

Publications (2)

Publication Number Publication Date
NO20000202D0 NO20000202D0 (no) 2000-01-14
NO20000202L true NO20000202L (no) 2000-02-10

Family

ID=26731289

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20000202A NO20000202L (no) 1997-07-17 2000-01-14 Immunogene konjugater som omfatter en gruppe B- meningokokkporin og et H. influenzae-polysakkarid

Country Status (12)

Country Link
US (2) US6451317B1 (no)
EP (1) EP1003549A4 (no)
JP (1) JP2001510169A (no)
KR (1) KR20010021953A (no)
CN (1) CN1272062A (no)
AU (1) AU748973B2 (no)
BR (1) BR9811475A (no)
CA (1) CA2297072A1 (no)
NO (1) NO20000202L (no)
NZ (1) NZ502437A (no)
PL (1) PL338146A1 (no)
WO (1) WO1999003501A1 (no)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2485940T3 (es) * 1998-05-29 2014-08-14 Novartis Vaccines And Diagnostics, Inc. Combinación de vacunas contra Meningitis B/C
US10967045B2 (en) 1998-11-02 2021-04-06 Secretary of State for Health and Social Care Multicomponent meningococcal vaccine
US20030215469A1 (en) * 1998-11-02 2003-11-20 Microbiological Research Authority Multicomponent meningococcal vaccine
GB9823978D0 (en) * 1998-11-02 1998-12-30 Microbiological Res Authority Multicomponent meningococcal vaccine
CN102580072A (zh) 1999-05-19 2012-07-18 诺华疫苗和诊断有限公司 组合式奈瑟球菌组合物
GB9928196D0 (en) * 1999-11-29 2000-01-26 Chiron Spa Combinations of B, C and other antigens
ES2507100T3 (es) * 2000-01-17 2014-10-14 Novartis Vaccines And Diagnostics S.R.L. Vacuna OMV suplementada contra meningococo
US20020192205A1 (en) * 2001-05-11 2002-12-19 Francis Michon Immunogenic compositions of low molecular weight hyaluronic acid and methods to prevent, treat and diagnose infections and diseases caused by group A and group C streptococci
MX339524B (es) * 2001-10-11 2016-05-30 Wyeth Corp Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedad meningococica.
GB0130123D0 (en) * 2001-12-17 2002-02-06 Microbiological Res Agency Outer membrane vesicle vaccine and its preparation
GB0213622D0 (en) * 2002-06-13 2002-07-24 Glaxosmithkline Biolog Sa Vaccine Corporation
GB0220194D0 (en) * 2002-08-30 2002-10-09 Chiron Spa Improved vesicles
GB0225736D0 (en) * 2002-11-05 2002-12-11 Adjuvantix Ltd T-Cell Independent Vaccine
EP2191844B1 (en) 2003-01-30 2014-03-05 Novartis AG Injectable vaccines against multiple meningococcal serogroups
GB0316560D0 (en) 2003-07-15 2003-08-20 Chiron Srl Vesicle filtration
GB0419627D0 (en) * 2004-09-03 2004-10-06 Chiron Srl Immunogenic bacterial vesicles with outer membrane proteins
GB0424092D0 (en) 2004-10-29 2004-12-01 Chiron Srl Immunogenic bacterial vesicles with outer membrane proteins
WO2007039583A1 (en) * 2005-09-30 2007-04-12 Lipoxen Technologies Limited Liposomal vaccine compositions comprising a polysaccharide antigen and a protein adjuvant
WO2009062050A2 (en) 2007-11-08 2009-05-14 Neogenix Oncology, Inc. Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers
CN103816870B (zh) 2008-12-03 2016-11-23 株式会社钟化 含有甲酰基的多孔性载体、使用该多孔性载体的吸附体以及它们的制造方法
CN104650241A (zh) * 2009-08-27 2015-05-27 诺华股份有限公司 包括脑膜炎球菌fHBP序列的杂交多肽
EP2613805B1 (en) 2010-09-10 2019-10-23 GlaxoSmithKline Biologicals SA Meningococcus overexpressing nada and/or nhba and outer membrane vesicles derived therefrom
SA115360586B1 (ar) 2012-03-09 2017-04-12 فايزر انك تركيبات لعلاج الالتهاب السحائي البكتيري وطرق لتحضيرها
AU2013320313B2 (en) 2012-09-18 2018-07-12 Glaxosmithkline Biologicals Sa Outer membrane vesicles
CA2923129C (en) 2013-09-08 2020-06-09 Pfizer Inc. Neisseria meningitidis compositions and methods thereof
CN109790194B (zh) 2016-11-23 2021-07-23 广州华睿光电材料有限公司 金属有机配合物、高聚物、组合物及有机电子器件
CA3052621A1 (en) 2017-02-03 2018-08-09 Schadeck, Eva Barbara Haemophilus influenzae saccharide-carrier conjugate compositions and uses thereof
CN107966436B (zh) * 2017-10-27 2020-10-02 中国农业大学 一种基于镉的功能核酸的可视化传感器及其应用
US20220372138A1 (en) 2019-07-05 2022-11-24 Iomx Therapeutics Ag Antibodies binding igc2 of igsf11 (vsig3) and uses thereof
US20240010720A1 (en) 2020-07-06 2024-01-11 Iomx Therapeutics Ag Antibodies binding igv of igsf11 (vsig3) and uses thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4356170A (en) * 1981-05-27 1982-10-26 Canadian Patents & Development Ltd. Immunogenic polysaccharide-protein conjugates
US4695624A (en) * 1984-05-10 1987-09-22 Merck & Co., Inc. Covalently-modified polyanionic bacterial polysaccharides, stable covalent conjugates of such polysaccharides and immunogenic proteins with bigeneric spacers, and methods of preparing such polysaccharides and conjugates and of confirming covalency
IT1187753B (it) * 1985-07-05 1987-12-23 Sclavo Spa Coniugati glicoproteici ad attivita' immunogenica trivalente
ES2051909T3 (es) * 1988-04-19 1994-07-01 American Cyanamid Co Vacuna del conjugado de polisacarido-proteina de membrana externa contra la haemophilus influenzae tipo b.
US5439808A (en) 1993-07-23 1995-08-08 North American Vaccine, Inc. Method for the high level expression, purification and refolding of the outer membrane group B porin proteins from Neisseria meningitidis
US6153406A (en) * 1993-07-23 2000-11-28 North American Vaccine, Inc. Method for the high level expression, purification and refolding of the outer membrane protein P2 from Haemophilus influenzae type B
US5747287A (en) 1995-04-28 1998-05-05 North American Vaccine, Inc. Method for the high level expression, purification and refolding of the outer membrane group B porin proteins from Neisseria meningitidis
WO1996040225A1 (en) * 1995-06-07 1996-12-19 Alberta Research Council Immunogenic and immunostimulatory oligosaccharide compositions and methods of making and using them
KR19990082265A (ko) 1996-02-01 1999-11-25 다니엘 제이. 압둔-나비 효모중에서 b군 나이세리아 멘인기티디스 외막(mb３)단백질을 발현시키는 방법 및 백신

Also Published As

Publication number Publication date
CN1272062A (zh) 2000-11-01
PL338146A1 (en) 2000-09-25
US6613336B2 (en) 2003-09-02
KR20010021953A (ko) 2001-03-15
BR9811475A (pt) 2000-08-15
CA2297072A1 (en) 1999-01-28
WO1999003501A9 (en) 1999-04-22
US20020131984A1 (en) 2002-09-19
NZ502437A (en) 2001-11-30
US6451317B1 (en) 2002-09-17
EP1003549A1 (en) 2000-05-31
NO20000202D0 (no) 2000-01-14
AU8494698A (en) 1999-02-10
JP2001510169A (ja) 2001-07-31
AU748973B2 (en) 2002-06-13
EP1003549A4 (en) 2005-03-02
WO1999003501A1 (en) 1999-01-28

Similar Documents

Publication Publication Date Title
NO20000202D0 (no) Immunogene konjugater som omfatter en gruppe B- meningokokkporin og et H. influenzae-polysakkarid
HUP0103100A3 (en) Immunogenic betha-propionamido-linked polysaccharide protein conjugate useful as a vaccine produced using an n-acryloylated polysaccharide
ATE121947T1 (de) Verbessertes meningokokkale polysaccharidkonjugatvakzin.
HUS1600040I1 (hu) Multivalens, meningokokkusz-eredetû poliszaccharid és fehérje konjugátumát tartalmazó vakcina
NO975513L (no) 3-hydroksypyridin-2-karboksylsyreamidester, fremstilling og anvendelse som legemiddel
ITMI951603A0 (it) Seggiolone a chiusura migliorata
ZA200201816B (en) A vaccine composition and method of using the same.
FI991275A (fi) Menetelmä kattilassa, erityisesti soodakattilassa
FR2746167B1 (fr) Raccord a emboitement, demontable
IS4382A (is) Ný peptíð með ónæmisbreytandi áhrif
GB9611673D0 (en) Meningococcal vaccine
FR2715304B1 (fr) Vaccin anti-allergique.
DK1053224T3 (da) Biphenylfulfonylcyanamider, fremgangsmåde til fremstilling deraf og anvendelse deraf som lægemiddel
ZA9710606B (en) Non-virulent Mycoplasma synoviae vaccine thereof.
AU2001288236A1 (en) Natural, non-allergenic, immune system stimulant
ITTO950214A0 (it) Rotore, in un generatore a magneti.
HUP0002359A3 (en) Immunogenic conjugates comprising a group b meningococcal porin and an h. influenzae polysaccharide
AU5681298A (en) Pneumococcal polysaccharide conjugate and pneumococcal polysaccharide chol era toxin b subunit conjugate vaccines
PL346645A1 (en) IMMUNOGENIC β-PROPIONAMIDO-LINKED POLYSACCHARIDE PROTEIN CONJUGATE USEFUL AS A VACCINE PRODUCED USING AN N-ACRYLOYLATED POLYSACCHARIDE
TR199800043A3 (tr) Pim-tipi eszamanlama cihazi.
DE69319144D1 (de) Biegbares, aufblasbares kissen
陈志杰 Applying the Communicative Approach in the Intensive Reading Class
AU2546600A (en) Neisseria meningitidis serogroup b antigen
AU2000271165A1 (en) Natural, non-allergenic, immune system stimulant
梁励敏 Cultural Confluence Promises Better Future

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application